Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma.

Tianxing DaiLinsen YeMingbin DengGuozhen LinRongqiang LiuHaoyuan YuWei LiuYang YangGuoying Wang

Published in: Journal of clinical and translational hepatology (2022)

Upregulated TMCO3 could act as an oncogenic mediator and promote sorafenib resistance in HCC, providing a potential therapeutic target for HCC treatment.

Keyphrases

poor prognosis
long non coding rna
transcription factor
cell proliferation
replacement therapy
smoking cessation